Preventing Ischemic Cerebrovascular Events in High-Risk Patients With Non-disabling Ischemic Cerebrovascular Events Using Remote Ischemic Conditioning : A Single-Arm Study

Copyright © 2021 Liu, Gao, Meng, Song, Tang, Zhao, Chen, Sheng, Fan, Jiang, Zhang, Ding, Huang, Ma, Dong, Xue, Yu, Duan, Chu, Chen, Huang, Li, Ovbiagele, Zhao, Ji and Feng..

Background: Secondary stroke prevention after a high-risk, non-disabling ischemic cerebrovascular event needs to be enhanced. The study was conducted to investigate whether remote ischemic conditioning (RIC) is effective in preventing recurrent ischemic events within 3 months. Methods: This was a four-center, single-arm, open-label Phase IIa futility trial (PICNIC-One Study). Adult patients (≥18 years of age) who had an acute minor ischemic stroke (AMIS) with a National Institutes of Health Stroke Scale score ≤ 3 or a transient ischemic attack (TIA) with moderate-to-high risk of stroke recurrence (ABCD score ≥ 4) within 14 days of symptom onset were recruited. Patients received RIC as adjunctive therapy to routine secondary stroke prevention regimen. RIC consisted of five cycles of 5-min inflation (200 mmHg) and 5-min deflation of cuffs (45 min) on bilateral upper limbs twice a day for 90 days. Results: A total of 285 patients met the study criteria, of which 167 provided signed informed consent and were enrolled. Data from 162 were analyzed with five subjects excluded. Recurrent AIS/TIA occurred in 6/162 (3.7%) patients within 3 months, with no occurrence of hemorrhagic stroke. The top three adverse events were upper limb pain (44/162, 27.2%), petechia (26/162, 16.0%), and heart palpitation (5/162, 3.1%). About 68 (42.0%) subjects completed ≥ 50% of 45-min RIC sessions. Conclusions: RIC is a safe add-on procedure and it has a potential benefit in reducing recurrent cerebrovascular events in patients with high-risk, non-disabling ischemic cerebrovascular events as the risk of stroke/TIA events is lower than expected; however, its compliance needs to be improved. Our study provides critical preliminary data to plan a large sample size, randomized controlled clinical study to systematically investigate the safety and efficacy of RIC in this population.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:12

Enthalten in:

Frontiers in neurology - 12(2021) vom: 18., Seite 748916

Sprache:

Englisch

Beteiligte Personen:

Liu, Shimeng [VerfasserIn]
Gao, Zongen [VerfasserIn]
Meng, Ran [VerfasserIn]
Song, Haiqing [VerfasserIn]
Tang, Tianping [VerfasserIn]
Zhao, Ya [VerfasserIn]
Chen, Rong [VerfasserIn]
Sheng, Yanzhen [VerfasserIn]
Fan, Qianqian [VerfasserIn]
Jiang, Fang [VerfasserIn]
Zhang, Qian [VerfasserIn]
Ding, Jianping [VerfasserIn]
Huang, Xiaoqin [VerfasserIn]
Ma, Qingfeng [VerfasserIn]
Dong, Kai [VerfasserIn]
Xue, Sufang [VerfasserIn]
Yu, Zhipeng [VerfasserIn]
Duan, Jiangang [VerfasserIn]
Chu, Changbiao [VerfasserIn]
Chen, Xiaohui [VerfasserIn]
Huang, Xingquan [VerfasserIn]
Li, Sijie [VerfasserIn]
Ovbiagele, Bruce [VerfasserIn]
Zhao, Wenle [VerfasserIn]
Ji, Xunming [VerfasserIn]
Feng, Wuwei [VerfasserIn]

Links:

Volltext

Themen:

Acute minor ischemic stroke
Journal Article
Remote ischemic conditioning
Secondary prevention
Stroke
Transient ischemic attack

Anmerkungen:

Date Revised 04.01.2022

published: Electronic-eCollection

Citation Status PubMed-not-MEDLINE

doi:

10.3389/fneur.2021.748916

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM335111998